Clofarabine, Cytarabine, and G-CSF in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
Status:
Completed
Trial end date:
2015-04-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy, such as clofarabine and cytarabine, work in different
ways to stop the growth of cancer cells, either by killing the cells or stopping them from
dividing. Colony stimulating factors, such as G-CSF, may increase the number of immune cells
found in bone marrow or peripheral blood and may help the immune system recover from the side
effects of chemotherapy.
PURPOSE: This phase I trial is studying the side effects and best dose of clofarabine to see
how well it works when given together with cytarabine and G-CSF in treating patients with
relapsed or refractory acute myeloid leukemia